These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 36067157)
1. Optimizing global COVID-19 vaccine allocation: An agent-based computational model of 148 countries. Li Q; Huang Y PLoS Comput Biol; 2022 Sep; 18(9):e1010463. PubMed ID: 36067157 [TBL] [Abstract][Full Text] [Related]
2. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Watson OJ; Barnsley G; Toor J; Hogan AB; Winskill P; Ghani AC Lancet Infect Dis; 2022 Sep; 22(9):1293-1302. PubMed ID: 35753318 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness. Pearson CAB; Bozzani F; Procter SR; Davies NG; Huda M; Jensen HT; Keogh-Brown M; Khalid M; Sweeney S; Torres-Rueda S; ; ; Eggo RM; Vassall A; Jit M PLoS Med; 2021 Oct; 18(10):e1003815. PubMed ID: 34606520 [TBL] [Abstract][Full Text] [Related]
4. COVAX and equitable access to COVID-19 vaccines. Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037 [TBL] [Abstract][Full Text] [Related]
5. Disparities and effectiveness of COVID-19 vaccine policies in three representative European countries. Xie W; Shi L; Liu M; Yang J; Ma M; Sun G Int J Equity Health; 2024 Jan; 23(1):16. PubMed ID: 38287322 [TBL] [Abstract][Full Text] [Related]
6. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. So AD; Woo J BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376 [TBL] [Abstract][Full Text] [Related]
7. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility. Eccleston-Turner M; Upton H Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737 [TBL] [Abstract][Full Text] [Related]
8. COVAX, vaccine donations and the politics of global vaccine inequity. de Bengy Puyvallée A; Storeng KT Global Health; 2022 Mar; 18(1):26. PubMed ID: 35248116 [TBL] [Abstract][Full Text] [Related]
9. WHO's allocation framework for COVAX: is it fair? Sharma S; Kawa N; Gomber A J Med Ethics; 2022 Jul; 48(7):434-438. PubMed ID: 33837046 [TBL] [Abstract][Full Text] [Related]
10. Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together. Rackimuthu S; Narain K; Lal A; Nawaz FA; Mohanan P; Essar MY; Charles Ashworth H Global Health; 2022 Feb; 18(1):23. PubMed ID: 35193616 [TBL] [Abstract][Full Text] [Related]
11. Risky business: COVAX and the financialization of global vaccine equity. Stein F Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439 [TBL] [Abstract][Full Text] [Related]
12. The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study. Clark RA; Mukandavire C; Portnoy A; Weerasuriya CK; Deol A; Scarponi D; Iskauskas A; Bakker R; Quaife M; Malhotra S; Gebreselassie N; Zignol M; Hutubessy RCW; Giersing B; Jit M; Harris RC; Menzies NA; White RG Lancet Glob Health; 2023 Apr; 11(4):e546-e555. PubMed ID: 36925175 [TBL] [Abstract][Full Text] [Related]
13. Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines. Buhat CAH; Lutero DSM; Olave YH; Quindala KM; Recreo MGP; Talabis DASJ; Torres MC; Tubay JM; Rabajante JF Appl Health Econ Health Policy; 2021 Sep; 19(5):699-708. PubMed ID: 34169485 [TBL] [Abstract][Full Text] [Related]
14. Inequities in the deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region, 2020-2021. Hasan Q; Elfakki E; Fahmy K; Mere O; Ghoniem A; Langar H; Musa N; Attia R; Othman MM; Samhouri D; Chaudhri I; Abubakar A; Hajjeh R; Hutin YJ BMJ Glob Health; 2022 Jun; 7(Suppl 4):. PubMed ID: 35764354 [TBL] [Abstract][Full Text] [Related]
15. Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study. Grenfell RFQ; Oyeyemi OT Pathog Glob Health; 2023 Mar; 117(2):152-166. PubMed ID: 35770309 [TBL] [Abstract][Full Text] [Related]
16. Attitudes Toward the Global Allocation of Chinese COVID-19 Vaccines: Cross-sectional Online Survey of Adults Living in China. Yu H; Du R; Wang M; Yu F; Yang J; Jiao L; Wang Z; Liu H; Wu P; Bärnighausen T; Xue L; Wang C; McMahon S; Geldsetzer P; Chen S JMIR Public Health Surveill; 2022 Jun; 8(6):e33484. PubMed ID: 35483084 [TBL] [Abstract][Full Text] [Related]
17. Scaling Up the Global COVID-19 Vaccination Program: Production, Allocation, and Distribution with an Emphasis on Equity. Louden EM Yale J Biol Med; 2022 Sep; 95(3):379-387. PubMed ID: 36187418 [TBL] [Abstract][Full Text] [Related]
18. Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants. Liu F; Zhao Z; Ma C; Nie X; Wu A; Li X Epidemiol Infect; 2022 Jan; 150():e46. PubMed ID: 35067231 [TBL] [Abstract][Full Text] [Related]
19. More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap. Borges LC; Zeferino de Menezes H; Crosbie E Int J Health Policy Manag; 2022 Dec; 11(12):3101-3113. PubMed ID: 36028975 [TBL] [Abstract][Full Text] [Related]